Group One Trading’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.79K Buy
787
+461
+141% +$2.78K ﹤0.01% 6842
2026
Q1
$2.01K Buy
+326
New +$2.71K ﹤0.01% 7055
2025
Q3
– Sell
-108,509
Closed -$952K – 9054
2025
Q2
$1.41M Buy
+108,509
New +$1.63M ﹤0.01% 2445
2024
Q2
– Sell
-282
Closed -$16.1K – 7386
2024
Q1
$14.5K Sell
282
-531
-65% -$26.1K ﹤0.01% 5642
2023
Q4
$32.8K Buy
+813
New +$23.8K ﹤0.01% 5371

Other funds holding RXST

Group One Trading's RXST Position: Q2 2026 in Review

Group One Trading increased its RxSight (RXST) stake by 141% in Q2 2026, buying an estimated $2.78K and bringing the position to 787 shares worth $3.79K. The position accounts for ﹤0.01% of the portfolio, ranked #6842.

Group One Trading first reported a position in RXST in Q4 2023 and has held it in 5 quarters since. The position peaked at $1.41M in Q2 2025. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Group One Trading held 787 shares of RxSight worth $3.79K as of Q2 2026.
  • Group One Trading bought 461 RxSight shares in Q2 2026, an estimated $2.78K.
  • RxSight made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #6842 holding.
  • Group One Trading first reported a position in RxSight in Q4 2023 and has held it in 5 quarters since.
  • Group One Trading's RxSight position peaked at $1.41M in Q2 2025.
  • 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.